[
  {
    "objectID": "index.html",
    "href": "index.html",
    "title": "Personal notes - epidemiology",
    "section": "",
    "text": "Welcome"
  },
  {
    "objectID": "intro.html",
    "href": "intro.html",
    "title": "1  Intro",
    "section": "",
    "text": "2 References"
  },
  {
    "objectID": "intro.html#longitudinal-studies",
    "href": "intro.html#longitudinal-studies",
    "title": "1  Intro",
    "section": "1.1 Longitudinal studies",
    "text": "1.1 Longitudinal studies\n\nLongitudinal studies are defined as studies in which the outcome variable is repeateadly measured; i.e. the outcome variable is measured in the same subject on several occasions.\n\nExtracted from Twisk (2013)\nCharacteristics: * observations of one subject over time are not independent of each other * statistics should consider that repeated observations of each subject are correlated * this studies bring the illusion than are solving causality but only we can try temporality\n\nStatistical notation\n\n\nnumber of\n\n\n\nsubjects\ni = 1 to N\n\n\nnumber of covariates\nj = 1 to J\n\n\nnumber of times a particular subject is\n\n\n\nmeasured\nt = 1 to T\n\n\noutcome variable\nY\n\n\ncovariates\nX\n\n\n\n\n\n\nImage extracted from Twisk (2013)"
  },
  {
    "objectID": "intro.html#cohort-studies",
    "href": "intro.html#cohort-studies",
    "title": "1  Intro",
    "section": "1.2 Cohort studies",
    "text": "1.2 Cohort studies\n\n1.2.1 Observational cohort studies\ncan be divided into: * prospective * The only one that can be characterized as longitudinal. * Analyze the longitudinal development of a certain characteristic over time (growth or deterioration). * tracking: “stability” of a certain characteristic over time\n\nretrospective\ncross-sectional\n\n\n\n1.2.2 Experimental cohort studies (clinical trials)\n\nare prospective (ie longitudinal).\nThe outcome variable Y is measured at least twice (the classical “pre-test,” “post-test” design).\n\nstringhini, 2018\nPremature mortality reduction from chronic diseases\nBiological Risk factors - high blood pressure - obesity - tobacco use - excess salt intake - diabetes - insufficient physical activity - alcohol consumption\nSocioeconomic status - occupational group - educational attainment - level of income and wealth - place of residence"
  },
  {
    "objectID": "intro.html#general-additive-mixed-model-gamm",
    "href": "intro.html#general-additive-mixed-model-gamm",
    "title": "1  Intro",
    "section": "1.3 General Additive Mixed Model (GAMM)",
    "text": "1.3 General Additive Mixed Model (GAMM)\nsemi-parametric model\nLet’s start with an equation for a Gaussian linear model:\ny=β0+x1β1+ε,ε∼N(0,σ2)\nWhat changes in a GAM is the presence of a smoothing term:\ny=β0+f(x1)+ε,ε∼N(0,σ2)\nThis term could be many things.\n\n1.3.1 Walking speed and age\nFixed Effects Predictors - age - height\nRandom Effect - study at the intercept and age slope\n\n\n1.3.2 Number of years of functioning lost (primary outcome)\nIt is based on the predictions of the previous model\nFixed Effects - age - age2 - height - year of birth - distances walked - risk factor under study (minimally adjusted model) - all risk factors (mutually adjusted models)\nCI - Model based parametric 5000 bootstrap samples\n\n\n1.3.3 Years of life lost (secundary outcome)\nDifference between the areas of the survival curves. Survival curves Kaplan-Meier adjusted curves, conditional on survival to age 60 years. They run a shared frality Cox model with age as time scale, stratified by the levels of the given risk factor and a year of birth as covariate (for minimally adjusted models) or year of birth and the remaining risk factors as covariates (mutually adjusted models)\nschrempft 2022"
  },
  {
    "objectID": "intro.html#pace-of-aging",
    "href": "intro.html#pace-of-aging",
    "title": "1  Intro",
    "section": "1.4 Pace of aging",
    "text": "1.4 Pace of aging\nsimilar to Dunedin Study investigators\n1 - Biomarkers were standarized for healthy men and women. Z-scores were reversed for HDL and creatinine clearence.\n2 - Mixed-effects models with a random interecept and a random linear slope, were used to calculate participants’ personal slopes (change in biomarkers per year) Each year included time, age a t baseline center in the samples mean, and a interaction term between the time and age at the baseline. For biomarkers that show a non linear trajectory, an additionally\n3 - The individual slopes for each biomarker (annual change in biomarker Z-score) wee aggregated to create a total Pace of Aging score.\nCovariates: - Alcohol &gt; 14 units - hipertensive or diabetic medication - pysical inactivity - smoking status\ncarmeli, 2019"
  },
  {
    "objectID": "intro.html#terms",
    "href": "intro.html#terms",
    "title": "1  Intro",
    "section": "1.5 Terms",
    "text": "1.5 Terms\n\nTerms used in this analysis\n\n\nTerm\nDefinition\n\n\n\n\nnon-communicable diseases/risk factors\n12\n\n\nspline\n\n\n\ncross-sectional study\n\n\n\nlongitudinal study"
  },
  {
    "objectID": "summary.html",
    "href": "summary.html",
    "title": "2  Summary",
    "section": "",
    "text": "In summary, this book has no content whatsoever.\n\n1 + 1\n\n[1] 2"
  },
  {
    "objectID": "references.html",
    "href": "references.html",
    "title": "References",
    "section": "",
    "text": "Twisk, Jos W. R. 2013. Applied Longitudinal Data Analysis for\nEpidemiology: A Practical Guide. 2nd ed. Cambridge University\nPress."
  }
]